Industry Reports
The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >
The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >
From The Drug Channels Blog
Tuesday, October 27, 2026
Drug Channels News Roundup, October 2026: Part D’s Hidden Cost Sharing Gap, 340B’s $244 Billion Footprint, The Net Price Rebate Model, Cigna’s Wholesale Push, and Four Ways to Bag a Drug
By Bryce Platt, PharmD Fall has brought a fresh round of questions about how drug channel economics affect patients, plans, and providers. more >
Friday, October 23, 2026
Copay + GTN Revenue Protection = Better Together
Today's guest post comes from Gerard Rivera, Co-Founder & CEO at RIS Rx. Gerard Rivera examines how copay programs and real-time gross-to-net (GTN) revenue protection can work together to more >